Project Grant HT94252410842
Award Date
9/15/24
Completion Date
9/14/27
Dollars Obligated
$1.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
The U.S. Department of Defense's Defense Health Agency awarded a $323,000 Project Grant with a performance period from March 1, 2024 to February 28, 2026 to The Methodist Hospital Research Institute Division. This grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports research to identify cardiac conduction system abnormalities in a myotonic dystrophy animal model using noninvasive techniques. The Methodist Hospital Research Institute has a track record...
The Department of the Army Medical Command, under the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded a $444,125 project grant to The Methodist Hospital Research Institute (HMRI) in Houston, Texas. The grant is for the "IDENTIFICATION OF LIAX BINDING PARTNERS FOR PREVENTING RESISTANCE" project, with a performance period from April 1, 2025 to March 31, 2027. HMRI, a prominent nonprofit research organization, will leverage its expertise in...
The Department of the Army Medical Command awarded The Methodist Hospital Research Institute $319,669 under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2021 through May 31, 2023. The project aims to investigate novel M2 lipogenic macrophages associated with fracture callus that are altered in type 2 diabetes. Baylor College of Medicine will serve as a sub-awardee to assist with the research. Through the support of basic, applied, and advanced...
The University of Houston received a $299,787 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund a research project from May 1, 2023 to April 30, 2025 to evaluate the diagnostic utility of antibodies to histone post-translational modifications in pediatric lupus patients. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...
The Defense Health Agency has awarded a $760,844.00 Project Grant to the Texas A&M University System Health Science Center to conduct research under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, awarded on September 15, 2023 with a completion date of September 14, 2026, will fund research titled "Targeting the MIF/CD74 Immune Axis to Treat GWI Astrocyte, Neuronal, and Cognitive Dysfunction." This research aims to investigate medical...
The Defense Health Agency awarded a $725,000 project grant to The University of Texas Southwestern Medical Center in Dallas, Texas, for research under the Military Medical Research and Development program. The three-year award beginning June 15, 2023, will support research into glutamine-targeted therapies to prevent traumatic heterotopic ossification. As the parent organization, the University of Texas System will provide research support services through this subaward. The Military Medical...
The Defense Health Agency awarded $145,570 to Rice University under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of September 30, 2021 through September 29, 2023. The project aims to develop mutation-targeted immunotherapy for the treatment of rare cancers. Through this funding, Rice University researchers will investigate medical solutions for cancer on the battlefield and for the general public. The grant supports basic, applied, and advanced...
The Defense Health Agency awarded a $492,927 Project Grant to The University of Texas Southwestern Medical Center in Dallas, Texas to conduct research on leveraging biophysicochemical motifs in T-cell receptor antigen binding regions and antigen co-occurrence to predict response to immune checkpoint inhibitors. This 3-year grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health...
The federal Project Grant award, with ID HT94252410992, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, totaling $2,710,479.00, will fund a research initiative led by the University of Texas M.D. Anderson Cancer Center to advance the understanding of metastatic breast cancer through the development of a comprehensive research platform. The award's performance period is from August 15, 2024 to...